Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2009

Oct 19, 2009

29831_dirs_2009-10-19_b94e6bb5-1e34-4bb9-bfba-f8dd91a53d7f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-10-15

Reporting Person: Ausiello Dennis A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-10-15 Common Stock A 887 Acquired 887 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 50 Indirect
Common Stock 1425 Indirect

Footnotes

F1: Received (together with $33.00 in cash for each share of Wyeth common stock) in exchange for 900 shares of Wyeth common stock in connection with the acquisition of Wyeth by Pfizer Inc. (the "Acquisition"). On the closing date of the Acquisition, the closing price of Wyeth's common stock was $50.39 per share.

F2: I hereby disclaim beneficial ownership of all shares held by members of my family.